Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $583.34 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HeartFlow, Inc. | $132.17 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $119.30 | 7 | $0 (2023) |
| CVRx, Inc. | $100.88 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $67.39 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $62.27 | 3 | $0 (2023) |
| PFIZER INC. | $38.53 | 2 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $29.66 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $18.23 | 1 | $0 (2022) |
| Amgen Inc. | $14.91 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $158.53 | 8 | Novartis Pharmaceuticals Corporation ($53.03) |
| 2022 | $410.45 | 15 | HeartFlow, Inc. ($132.17) |
| 2017 | $14.36 | 1 | Novartis Pharmaceuticals Corporation ($14.36) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Cardiovascular | ||||||
| 05/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardiology | ||||||
| 04/17/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $9.83 | General |
| Category: Heart Failure and Hypertension | ||||||
| 02/22/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.77 | General |
| Category: Cardiovascular | ||||||
| 12/13/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Cardiovascular | ||||||
| 11/01/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/01/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $11.82 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/25/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Cardiovascular | ||||||
| 09/27/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $65.25 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/16/2022 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $132.17 | General |
| Category: Coronary | ||||||
| 07/27/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| 05/19/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Cardiovascular | ||||||
| 05/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: Cardiovascular | ||||||
| 05/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/07/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/31/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 413 | 450 | $116,593 | $30,981 |
| 2022 | 10 | 373 | 403 | $67,809 | $24,746 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 136 | 138 | $49,252 | $7,165 | 14.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 24 | 24 | $20,640 | $4,014 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 33 | $8,085 | $3,847 | 47.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 59 | $7,756 | $3,667 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 42 | $8,001 | $3,358 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 30 | $7,490 | $3,162 | 42.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $5,005 | $1,755 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,399 | $1,657 | 37.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 15 | $2,808 | $1,422 | 50.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 39 | $1,755 | $370.26 | 21.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 21 | 21 | $777.00 | $339.36 | 43.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 21 | 21 | $625.00 | $225.00 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 136 | 137 | $34,559 | $7,435 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 33 | $7,029 | $4,593 | 65.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $7,502 | $3,713 | 49.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 18 | 18 | $5,490 | $2,909 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 27 | $4,266 | $2,669 | 62.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 20 | $2,560 | $1,095 | 42.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 14 | 14 | $1,666 | $840.57 | 50.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 62 | 72 | $3,240 | $778.85 | 24.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 25 | 25 | $925.00 | $420.61 | 45.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 26 | 26 | $572.00 | $291.64 | 51.0% |
About Dr. Darrell Rubin, MD
Dr. Darrell Rubin, MD is a Cardiovascular Disease healthcare provider based in Somerset, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700095072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darrell Rubin, MD has received a total of $583.34 in payments from pharmaceutical and medical device companies, with $158.53 received in 2023. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($583.34).
As a Medicare-enrolled provider, Rubin has provided services to 786 Medicare beneficiaries, totaling 853 services with total Medicare billing of $55,727. Data is available for 2 years (2022–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Somerset, PA
- Active Since 05/22/2007
- Last Updated 06/22/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1700095072
Products in Payments
- FFRct (Device) $132.17
- ELIQUIS (Drug) $122.23
- Barostim Neo System (Device) $100.88
- XARELTO (Drug) $62.27
- ENTRESTO (Drug) $45.36
- LifeVest (Device) $29.66
- CAMZYOS (Drug) $22.41
- LEQVIO (Drug) $22.03
- VERQUVO (Drug) $18.23
- Repatha (Biological) $14.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Somerset
Dr. Jack Stroh, M.d, M.D
Cardiovascular Disease — Payments: $149,986
Dr. Genevieve Everett-Sigwalt, M.d, M.D
Cardiovascular Disease — Payments: $17,807
Natarajan Thannoli, Md, MD
Cardiovascular Disease — Payments: $10,564
George Bou Samra, M.d, M.D
Cardiovascular Disease — Payments: $8,135
Mrs. Ginger Combs, Arnp Rn, ARNP RN
Cardiovascular Disease — Payments: $2,051
Jennifer Wellings, M.d, M.D
Cardiovascular Disease — Payments: $1,965